• Fri, November 11, 2022

Michael Schmidt Maintained (ZNTL) at Strong Buy with Decreased Target to $28 on, Nov 11th, 2022

Michael Schmidt of Guggenheim, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $55 to $28 on, Nov 11th, 2022.

Michael has made no other calls on ZNTL in the last 4 months.



There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 0 agree with Michael's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Michael


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Thursday, November 10th, 2022
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $50 on, Thursday, November 10th, 2022
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $58 on, Wednesday, November 9th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022

Like: 👍